WHO SMART Guidelines - HIV
1.0.0 - release
WHO SMART Guidelines - HIV
1.0.0 - release
This page is part of the WHO SMART Guidelines - HIV (v1.0.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://smart.who.int/hiv/ValueSet/HIV.C.DE17 | Version: 1.0.0 | |||
| Active as of 2025-07-08 | Computable Name: HIVCDE17 | |||
Value set of HIV pre-exposure prophylaxis (PrEP) regimen
References
http://smart.who.int/hiv/CodeSystem/HIVConcepts| Code | Display | Definition |
| HIV.C.DE18 | TDF + FTC | Treated with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE19 | TDF | Treated with single-agent tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE20 | TDF + 3TC | Treated with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE21 | Other TDF-based regimen | Treated with other tenofovir disoproxil fumarate (TDF)-based regimen (oral PrEP) |
| HIV.C.DE22 | Dapivirine vaginal ring (DVR) | Dapivirine vaginal ring (DVR) for HIV prevention |
| HIV.C.DE23 | CAB-LA | Long-acting injectable cabotegravir |
Expansion performed internally based on codesystem WHO SMART HIV Concepts CodeSystem v1.0.0 (CodeSystem)
This value set contains 6 concepts
| Code | System | Display (en-US) | Definition |
| HIV.C.DE18 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + FTC | Treated with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE19 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF | Treated with single-agent tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE20 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | TDF + 3TC | Treated with tenofovir disoproxil fumarate (TDF) and lamivudine (3TC) pre-exposure prophylaxis (PrEP) regimen (oral PrEP) |
| HIV.C.DE21 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Other TDF-based regimen | Treated with other tenofovir disoproxil fumarate (TDF)-based regimen (oral PrEP) |
| HIV.C.DE22 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | Dapivirine vaginal ring (DVR) | Dapivirine vaginal ring (DVR) for HIV prevention |
| HIV.C.DE23 | http://smart.who.int/hiv/CodeSystem/HIVConcepts | CAB-LA | Long-acting injectable cabotegravir |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |